# The effects of vaginal gel from Myrtus communis on the sexual function of married women during reproductive aging: A study protocol for a randomized controlled trial

**Authors:** Bahareh khajehpour, Raheleh Babazadeh, Roshanak Salari, Jamshid Jamali, Malihe Mahmoudinia, Akingbolabo Ogunlakin, Akingbolabo Ogunlakin, Akingbolabo Ogunlakin, Akingbolabo Ogunlakin

PMC · DOI: 10.1371/journal.pone.0338732 · PLOS One · 2026-01-13

## TL;DR

This study will test if a vaginal gel made from Myrtus communis improves sexual function in women of reproductive age.

## Contribution

A novel clinical trial protocol to evaluate a natural vaginal gel for female sexual dysfunction.

## Key findings

- The study will assess the efficacy of Myrtus communis vaginal gel on sexual function.
- Blinded assessments will be conducted before and after treatment to measure outcomes.
- The trial design meets high-quality phase II clinical trial standards.

## Abstract

Human sexuality is an important aspect of functionality, and many patients believe that it determines their quality of life. Sexual dysfunction can lead to stress, strained relationships, and a decrease in self-esteem. The majority of modern medical treatments for improving female sexual function are associated with significant side effects and high costs. Traditionally, M. communis has been used to treat sexual impotence. Here, we present the protocol of an interventional clinical phase II study to test the hypothesis that vaginal gel containing Myrtus communis extract can improve sexual function in women of reproductive age.

In a prospective, randomized, placebo-controlled and highly blind clinical phase II trial, 80 women aged 18--40 years with sexual dysfunction meeting the inclusion criteria will be randomized to an intervention group receiving a vaginal gel containing myrtle leaf extract (n = 38) or an active control group receiving a placebo gel with an identical appearance (n = 38). Randomization will be performed via a permuted block technique with random allocation software. This study will be conducted at the women’s clinic of Imam Reza Hospital in Mashhad. Blinded assessments of outcome variables will be conducted twice: before treatment and one month after treatment. The primary outcome measure was sexual function.

This randomized controlled clinical trial evaluates the efficacy of the vaginal gel Myrtus communis on the sexual function of married women during reproductive age. The study design presented here fulfills the criteria of a high-quality clinical phase II trial of sexual function.

IRCT.behdasht.gov.ir Identifier: IRCT20230723058892N1

## Linked entities

- **Diseases:** sexual dysfunction (MONDO:0002134)
- **Species:** Myrtus communis (taxon 119949)

## Full-text entities

- **Genes:** CYP19A1 (cytochrome P450 family 19 subfamily A member 1) [NCBI Gene 1588] {aka ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX}
- **Diseases:** psychological disorders (MESH:D000067073), sexual disorders (MESH:D012734), Sexual Problems (MESH:D050035), mental disorders (MESH:D001523), Vaginal Atrophy (MESH:D014627), digestive and urinary system disorders (MESH:D004066), Vulvovaginal Atrophy (MESH:D014848), wounds (MESH:D014947), Anxiety (MESH:D001007), Symptom (MESH:D012816), cardiovascular disease (MESH:D002318), Genitourinary syndrome (MESH:D014564), Hypoactive sexual desire disorder (MESH:D020018), ORCID iD (MESH:C535742), endometriosis (MESH:D004715), cancer (MESH:D009369), neurological disorders (MESH:D009461), Female Sexual Dysfunction (MESH:D012735), alcohol and drug abuse (MESH:D019966), dyspareunia (MESH:D004414), Depression (MESH:D003866), AUB (MESH:D014592), FSFI (MESH:C566784), infertility (MESH:D007246), diabetes (MESH:D003920), MBS (MESH:C535807), sexual impotence (MESH:D007172), sexual pain (MESH:D010146)
- **Chemicals:** ascorbic acid (MESH:D001205), BABA (MESH:C047667), coumarins (MESH:D003374), gallic acid (MESH:D005707), 1,8 cineol (MESH:D000077591), water (MESH:D014867), phenols (MESH:D010636), catechin (MESH:D002392), steroids (MESH:D013256), delta cadinene (MESH:C000607799), AABB (-), essential oils (MESH:D009822), Carbomer (MESH:C479038), quercetin (MESH:D011794), flavonoids (MESH:D005419), sodium carbonate (MESH:C005686), testosterone (MESH:D013739), BBAA (MESH:C064408), myricetin (MESH:C040015), tannins (MESH:D013634), polyphenols (MESH:D059808)
- **Species:** Commiphora myrrha (myrrh, species) [taxon 318982], Nigella sativa (black-caraway, species) [taxon 555479], Zingiber officinale (ginger, species) [taxon 94328], Pistacia vera (pistachio, species) [taxon 55513], Myrtus communis (species) [taxon 119949], Homo sapiens (human, species) [taxon 9606], Panax ginseng (Asiatic ginseng, species) [taxon 4054], Eucalyptus (genus) [taxon 3932], Malus domestica (apple, species) [taxon 3750]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12798978/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12798978/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12798978/full.md

---
Source: https://tomesphere.com/paper/PMC12798978